Coronary atherosclerotic cardiovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Sign the informed consent; 2.Age 18-80 years old, no gender limit; 3.Diagnosed with coronary atherosclerosis and cardiovascular disease, coexisting one of the following conditions: 1) Two or more episodes of ACS within two years 2) Multivessel coronary artery disease (two or more main coronary arteries stenosis more than 50%) 3) Recent ACS (within 1 year) 4) Heart, brain or peripheral multivascular bed atherosclerotic vascular disease 5) LDL-C >= 4.9 mmol/L (190 mg/dl) 6) Diabetes 4. Can be contacted by phone, willing to cooperate with the pharmacist for follow-up.
Exclusion criteria
Exclusion criteria: 1. Mental disorders, unable to communicate normally; 2. There are serious/severe coexisting diseases whose life expectancy may be less than 6 months; 3. Pregnant or lactating women; 4. In patients with severe renal insufficiency, the clearance rate of endogenous creatinine is less than 30 ml/min; 5. Active liver disease or liver dysfunction, ALT is greater than 3 times the normal value and/or total bilirubin is greater than 2 times; 6. New York Heart Association (NYHA) grade IV heart failure; 7. Patients who participated in other clinical trials in the past 3 months; 8. Non-cooperative persons (who cannot cooperate with diet control, or those who do not follow the prescribed medication and affect the curative effect); 9. Other reasons that the researcher thinks are not suitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Low-density lipoprotein; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholesterol;Morisky-8 scale evaluation results;Disease and drug cognition;EuroQol-5 Dimensions (EQ-5D); | — |
Countries
China
Contacts
Zhejiang Provincial People's Hospital